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Abstract
Osteonecrosis after craniofacial radiation (ORN), osteomyelitis and bisphosphonates related necrosis of the jaw
(BRONJ) are the predominant bone diseases in Cranio- and Maxillofacial surgery. Although various hypothesis for
the pathophysiological mechanisms including infection, altered vascularisation or remodelling exist, the treatment
is still a challenge for clinicians. As the classical pharmacological or surgical treatment protocols have only limited
success, stem cells might be a promising treatment option, indicated by recently published data.
In maxillofacial surgery clinicians face three diseases of the
jaws predominantly: osteonecrosis after craniofacial radia-
tion (ORN), osteomyelitis and bisphosphonates related
necrosis of the jaw (BRONJ). Numerous reports exist sug-
gesting various pathological mechanisms and treatment
modalities for these diseases [1,2]. Although these publica-
tions elucidate the prevalence, risk factors and treatment
strategies, they have provided limited data on details of the
underlying pathophysiology, especially differences in the
three above mentioned diseases. The local or total immun-
supressive therapy of many patients (e.g. cancer patients)
and the universal presence of hundreds of microorganisms
in the oral cavity provide a perfect environment for
chronic infections like osteomyelitis. It is unclear if this
contributes to BROMJ too. Currently, most evidence exist
that the necrotic tissue becomes infected as opposed to
the infected tissue becomes necrotic [3]. Regarding the
effects on the immune system inconsistent data are
reported in the literature. On the one hand bisphospho-
nates inhibit T lymphocyte activation and proliferation
and suppress monocytes production of various pro-inflam-
matory cytokines [4]. On the other hand they increase the
production of pro-inflammatory cytokines by lymphocytes
[5]. Whereas the most widely accepted theory to explain
the cause of ORN is the theory of hypoxia, radio-induced
hypovascularity and hypocellularity [6,7] there is no evi-
dence that the necrotic regions in BRONJ have reduced
vasculature or blood supply. However, antiangiogenic
effects of bisphosphonates have been reported by other
authors [8]. Remoddeling suppression is an other causative
factor held responsible for BRONJ despite the fact that
there are no published data in humans showing the effects
of bisphosphonates on jaw remodeling [2]. Taken together
there are only very few studies (e.g. animal studies) clarify-
ing the basic pathophysiological mechanisms of these
bone diseases. Very recently, a new treatment modality
was introduced elucidating one possible causative factor
for BRONJ. Kikuiri and coworkers infused mesenchymal
stem cells in BRONJ-like mice. The stem cells modulated
the immune system, prevent and cure BRONJ-like disease
[9]. Since it is known, that stem cells can induce ectopic
bone formation [10] as well as angiogenesis [11], stem
cells might be a future treatment option for the above
mentioned bone diseases. Particularly, with respect to the
full capacity of various stem cell lines [12,13], these cells
might become a promising tool for clinicians.
Received: 3 January 2011 Accepted: 18 February 2011
Published: 18 February 2011
References
1. Allen MR, Burr DB: The pathogenesis of bisphosphonate-related
osteonecrosis of the jaw: so many hypotheses, so few data. J Oral
Maxillofac Surg 2009, 67:61-70.
2. Allen MR: Bisphosphonates and osteonecrosis of the jaw: moving from
the bedside to the bench. Cells Tissues Organs 2009, 189:289-294.
3. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S: Osteonecrosis
of the jaw induced by orally administered bisphosphonates: incidence,
clinical features, predisposing factors and treatment outcome.
Osteoporos Int 2007, 18:1363-1370.
4. Sansoni P, Passeri G, Fagnoni F, Mohagheghpour N, Snelli G, Brianti V,
Engleman EG: Inhibition of antigen-presenting cell function by
alendronate in vitro. J Bone Miner Res 1995, 10:1719-1725. * Correspondence: praxis@mkg-muenster.de
Department for Cranio- and Maxillofacial Surgery, Heinrich-Heine-University,
Moorenstr. 5, D-40225 Düsseldorf, Germany
Handschel and Meyer Head & Face Medicine 2011, 7:5
http://www.head-face-med.com/content/7/1/5
HEAD & FACE MEDICINE
© 2011 Handschel and Meyer; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.5. Coxon FP, Thompson K, Rogers MJ: Recent advances in understanding
the mechanism of action of bisphosphonates. Curr Opin Pharmacol 2006,
6:307-312.
6. Chrcanovic BR, Reher P, Sousa AA, Harris M: Osteoradionecrosis of the
jaws–a current overview–part 1: Physiopathology and risk and
predisposing factors. Oral Maxillofac Surg 2010, 14:3-16.
7. Prott FJ, Handschel J, Micke O, Sunderkotter C, Meyer U, Piffko J: Long-term
alterations of oral mucosa in radiotherapy patients. Int J Radiat Oncol Biol
Phys 2002, 54:203-210.
8. Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Foidart JM, Castronovo V,
Green JR: Novel antiangiogenic effects of the bisphosphonate
compound zoledronic acid. J Pharmacol Exp Ther 2002, 302:1055-1061.
9. Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen W,
Wang S, Le AD, Shi S: Cell-based immunotherapy with mesenchymal
stem cells cures bisphosphonate-related osteonecrosis of the jaw-like
disease in mice. J Bone Miner Res 2010, 25:1668-1679.
10. Handschel J, Naujoks C, Langenbach F, Berr K, Depprich RA,
Ommerborn MA, Kubler NR, Brinkmann M, Kogler G, Meyer U: Comparison
of ectopic bone formation of embryonic stem cells and cord blood stem
cells in vivo. Tissue Eng Part A 2010, 16:2475-2483.
11. Luo JZ, Xiong F, Al-Homsi AS, Roy T, Luo LG: Human BM stem cells initiate
angiogenesis in human islets in vitro. Bone Marrow Transplant 2010.
12. Meyer U, Meyer T, Handschel J, Wiesmann HP: Fundamentals of Tissue
Engineering and Regenerative Medicine Berlin, Heidelberg: Springer-Verlag;
2009.
13. Handschel J, Berr K, Depprich RA, Kubler NR, Naujoks C, Wiesmann HP,
Ommerborn MA, Meyer U: Induction of osteogenic markers in
differentially treated cultures of embryonic stem cells. Head Face Med
2008, 4:10.
doi:10.1186/1746-160X-7-5
Cite this article as: Handschel and Meyer: Infection, vascularization,
remodelling - are stem cells the answers for bone diseases of the jaws?
Head & Face Medicine 2011 7:5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Handschel and Meyer Head & Face Medicine 2011, 7:5
http://www.head-face-med.com/content/7/1/5
Page 2 of 2